INTEGRA LIFESCIENCES HOLDINGS CORP Capital Expenditures Incurred but Not yet Paid
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Capital Expenditures Incurred but Not yet Paid of $7.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP capital expenditures incurred but not yet paid for fiscal 2025 was $7.50M, a 39.02% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP capital expenditures incurred but not yet paid for fiscal 2024 was $12.30M, a 23.00% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP capital expenditures incurred but not yet paid for fiscal 2023 was $10.00M, a 4.76% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP capital expenditures incurred but not yet paid for fiscal 2022 was $10.50M, a 123.40% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|
| 2025-12-31 | $7.50M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $12.30M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $10.00M 10-K · filed 2026-02-26 | |
| 2022-12-31 | $10.50M 10-K · filed 2025-02-25 | |
| 2021-12-31 | $4.70M 10-K · filed 2024-02-28 | |
| 2020-12-31 | $1.60M 10-K · filed 2023-02-22 | |
| 2019-12-31 | $11.00M 10-K · filed 2022-02-24 | |
| 2018-12-31 | $5.40M 10-K · filed 2021-02-23 | |
| 2017-12-31 | $7.80M 10-K · filed 2020-02-21 | |
| 2016-12-31 | $4.70M 10-K · filed 2019-02-26 | |
| 2015-12-31 | $4.70M 10-K · filed 2018-03-01 | |
| 2014-12-31 | $3.30M 10-K · filed 2017-02-23 | $3.60M 10-K · filed 2015-02-27 |
| 2013-12-31 | $8.10M 10-K · filed 2016-02-26 | $8.60M 10-K · filed 2014-02-27 |
| 2012-12-31 | $9.50M 10-K · filed 2015-02-27 | |
| 2011-12-31 | $6.40M 8-K · filed 2014-06-20 | |
| 2010-12-31 | $1.10M 10-K · filed 2013-02-26 | |
| 2009-12-31 | $1.00M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |